These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23548017)

  • 1. Tenofovir treatment of the severe acute hepatitis B.
    Casals-Seoane F; Arberas-Díez B; García-Buey L
    Rev Esp Enferm Dig; 2013 Jan; 105(1):57-8. PubMed ID: 23548017
    [No Abstract]   [Full Text] [Related]  

  • 2. Report from the 2nd International Workshop on HIV and Hepatitis Co-Infection, January 12-14, 2006, Amsterdam, Netherlands. Tenofovir or adefovir for hepatitis B.
    TreatmentUpdate; 2006; 18(2):4. PubMed ID: 17228455
    [No Abstract]   [Full Text] [Related]  

  • 3. [Failure to treat hepatitis B virus infection with adefovir due to early selection of rtA181T mutation].
    Rodríguez Dominguez M; de la Loma GA; Moreira Vicente V; Mateos Lindemann M
    Med Clin (Barc); 2010 Apr; 134(10):468-9. PubMed ID: 19464708
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of hepatitis B virus infection and related cryoglobulinaemic purpura with nucleoside/nucleotide analogues.
    D'Amico E; Pace-Palitti V; Di Lembo E; Palazzi C
    Clin Exp Rheumatol; 2013; 31(1):155. PubMed ID: 23190931
    [No Abstract]   [Full Text] [Related]  

  • 5. Reactivation of viral replication after replacement of tenofovir by adefovir.
    van Bömmel F; Berg T
    Hepatology; 2005 Jul; 42(1):239-40. PubMed ID: 15962310
    [No Abstract]   [Full Text] [Related]  

  • 6. Adefovir dipivoxil for chemotherapy-induced activation of hepatitis B virus infection.
    Pérez-Roldán F; González-Carro P; Villafáñez-García MC
    N Engl J Med; 2005 Jan; 352(3):310-1. PubMed ID: 15659742
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of combined antiviral therapy with lamivudine and tenofovir in a liver transplanted girl with de novo hepatitis B virus infection.
    Tufano M; Liccardo D; Riva S; Candusso M; Torre G; Iorio R
    Transpl Infect Dis; 2013 Apr; 15(2):E81-4. PubMed ID: 23387823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological treatment of acute hepatitis B].
    García-Alonso FJ; Martín-Mateos RM; Moreira Vicente V
    Med Clin (Barc); 2012 May; 138(14):633-7. PubMed ID: 22118973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protocol for the antiviral therapy of hepatitis B and D].
    ; ; Gervain J; Horváth G; Hunyady B; Makara M; Pár A; Szalay F; Tornai I; Telegdy L
    Orv Hetil; 2010 Jan; 151(1):24-8. PubMed ID: 20031523
    [No Abstract]   [Full Text] [Related]  

  • 10. Lamivudine plus tenofovir versus lamivudine plus adefovir for the treatment of hepatitis B virus in HIV-coinfected patients, starting antiretroviral therapy.
    Sarkar J; Saha D; Bandyopadhyay B; Saha B; Chakravarty R; Guha SK
    Indian J Med Microbiol; 2018; 36(2):217-223. PubMed ID: 30084414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Patient with HBsAg negativization during treatment. Could it be considered a cure for hepatitis B?].
    Rodríguez Gil FJ; Gallego Pérez B; Gajownik U; García Belmonte D; Marín Bernabé CM; Martínez Crespo JJ
    Gastroenterol Hepatol; 2014 May; 37(5):324-6. PubMed ID: 24569137
    [No Abstract]   [Full Text] [Related]  

  • 12. Tenofovir-emtricitabine therapy for the prevention of hepatitis B recurrence in four patients after liver transplantation.
    McGonigal KH; Bajjoka IE; Abouljoud MS
    Pharmacotherapy; 2013 Sep; 33(9):e170-6. PubMed ID: 23744810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reactivation of hepatitis B treated with adefovir after infliximab administration].
    Núñez-Rodríguez MH; Santamaría-Martínez A; Mata-Román L; Caro-Patón A
    Med Clin (Barc); 2006 Apr; 126(14):558-9. PubMed ID: 16756915
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infections.
    Painter GR; Almond MR; Trost LC; Lampert BM; Neyts J; De Clercq E; Korba BE; Aldern KA; Beadle JR; Hostetler KY
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3505-9. PubMed ID: 17646420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir?
    Sadler MD; Lee SS
    Aliment Pharmacol Ther; 2014 Jun; 39(11):1339. PubMed ID: 24803253
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients.
    Bradshaw D; Danta M
    Aliment Pharmacol Ther; 2014 May; 39(9):992. PubMed ID: 24689343
    [No Abstract]   [Full Text] [Related]  

  • 17. WHO survey finds half of countries do not have clinical guidelines for treating hepatitis.
    Gulland A
    BMJ; 2013 Jul; 347():f4715. PubMed ID: 23884975
    [No Abstract]   [Full Text] [Related]  

  • 18. First report of successful clearance of hepatitis B and D coinfection with tenofovir monotherapy.
    James G; Sidhu P; Raza M
    Hepatology; 2015 Jul; 62(1):317-8. PubMed ID: 25234819
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir? Authors' reply.
    Gao L; Trinh HN; Li J; Nguyen MH
    Aliment Pharmacol Ther; 2014 Jun; 39(11):1339-40. PubMed ID: 24803254
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients--authors' reply.
    Gao L; Trinh HN; Li J; Nguyen MH
    Aliment Pharmacol Ther; 2014 May; 39(9):993. PubMed ID: 24689344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.